SK284049B6 - Orálny prostriedok a spôsob jeho prípravy - Google Patents

Orálny prostriedok a spôsob jeho prípravy Download PDF

Info

Publication number
SK284049B6
SK284049B6 SK307-2001A SK3072001A SK284049B6 SK 284049 B6 SK284049 B6 SK 284049B6 SK 3072001 A SK3072001 A SK 3072001A SK 284049 B6 SK284049 B6 SK 284049B6
Authority
SK
Slovakia
Prior art keywords
cross
composition
cellulose derivative
entacapone
linked cellulose
Prior art date
Application number
SK307-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK3072001A3 (en
Inventor
Kari Vahervuo
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284049(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of SK3072001A3 publication Critical patent/SK3072001A3/sk
Publication of SK284049B6 publication Critical patent/SK284049B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
SK307-2001A 1998-09-14 1999-09-13 Orálny prostriedok a spôsob jeho prípravy SK284049B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives
PCT/FI1999/000740 WO2000015196A1 (en) 1998-09-14 1999-09-13 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Publications (2)

Publication Number Publication Date
SK3072001A3 SK3072001A3 (en) 2002-05-09
SK284049B6 true SK284049B6 (sk) 2004-08-03

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
SK307-2001A SK284049B6 (sk) 1998-09-14 1999-09-13 Orálny prostriedok a spôsob jeho prípravy

Country Status (39)

Country Link
US (1) US6599530B2 (de)
EP (1) EP1112065B1 (de)
JP (1) JP4619537B2 (de)
KR (1) KR100732187B1 (de)
CN (1) CN1151778C (de)
AR (1) AR021806A1 (de)
AT (1) ATE256454T1 (de)
AU (1) AU746889B2 (de)
BG (1) BG65041B1 (de)
BR (1) BR9913681A (de)
CA (1) CA2342634C (de)
CO (1) CO5130008A1 (de)
CZ (1) CZ293960B6 (de)
DE (1) DE69913714T2 (de)
DK (1) DK1112065T3 (de)
EA (1) EA003282B1 (de)
EE (1) EE04657B1 (de)
ES (1) ES2213381T3 (de)
GE (1) GEP20033062B (de)
HK (1) HK1039750B (de)
HR (1) HRP20010277B1 (de)
HU (1) HU228910B1 (de)
ID (1) ID29026A (de)
IL (1) IL141681A0 (de)
ME (1) ME00706B (de)
MY (1) MY124394A (de)
NO (1) NO331641B1 (de)
NZ (1) NZ510583A (de)
PE (1) PE20001060A1 (de)
PL (1) PL193454B1 (de)
PT (1) PT1112065E (de)
RS (1) RS49723B (de)
SI (1) SI1112065T1 (de)
SK (1) SK284049B6 (de)
TR (1) TR200100752T2 (de)
TW (1) TWI222367B (de)
UA (1) UA73925C2 (de)
WO (1) WO2000015196A1 (de)
ZA (1) ZA200102084B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
JP2008519811A (ja) 2004-11-10 2008-06-12 オリオン コーポレーション 下肢静止不能症候群の治療
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
EA013161B1 (ru) * 2005-06-08 2010-02-26 Орион Корпорейшн Дозированная форма для перорального применения
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (de) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Verwendung von Entacapon für kosmetische, dermatologische und pharmazeutische Zusammensetzungen
RU2010136934A (ru) * 2008-02-06 2012-03-20 Вокхард Рисерч Сентер (In) Фармацевтические композиции энтакапона, микронизированного с сахарными спиртами
JP5466179B2 (ja) * 2008-02-06 2014-04-09 ウォックハート リサーチ センター 生物学的利用能が改善されたエンタカポン、レボドパ及びカルビドパの医薬組成物
NZ591326A (en) * 2008-08-22 2012-12-21 Wockhardt Research Center An extended release pharmaceutical composition of entacapone or salts thereof
JP5718937B2 (ja) * 2009-12-25 2015-05-13 イノファーマックス インコーポレイテッド パーキンソン病を治療するための医薬組成物及びその調製方法
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
EP2702991A4 (de) * 2011-04-26 2015-02-18 Innopharmax Inc Zusammensetzung von entacopon
WO2016083863A1 (en) 2014-11-28 2016-06-02 Bial - Portela & Ca, S.A. Medicaments for slowing parkinson's disease
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (de) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Zusammensetzung mit verzögerter freisetzung mit mikronisiertem tolcapon
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301006B1 (de) * 1986-04-01 1992-05-06 The Upjohn Company Methylprednisolon/natriumcarboxymethylstärke-tablettenmischung
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Also Published As

Publication number Publication date
BR9913681A (pt) 2001-06-05
RS49723B (sr) 2007-12-31
JP2002524493A (ja) 2002-08-06
ATE256454T1 (de) 2004-01-15
ID29026A (id) 2001-07-26
BG65041B1 (bg) 2007-01-31
HK1039750B (zh) 2005-02-18
NZ510583A (en) 2002-09-27
EA003282B1 (ru) 2003-04-24
HU228910B1 (en) 2013-06-28
SI1112065T1 (en) 2004-04-30
IL141681A0 (en) 2002-03-10
CN1319005A (zh) 2001-10-24
CZ2001792A3 (cs) 2001-08-15
US20020132009A1 (en) 2002-09-19
TR200100752T2 (tr) 2001-10-22
CZ293960B6 (cs) 2004-08-18
DE69913714T2 (de) 2004-10-07
TWI222367B (en) 2004-10-21
ZA200102084B (en) 2002-06-13
HRP20010277B1 (en) 2010-10-31
PL346618A1 (en) 2002-02-25
KR20010075084A (ko) 2001-08-09
WO2000015196A1 (en) 2000-03-23
UA73925C2 (uk) 2005-10-17
ME00706B (me) 2007-12-31
YU19301A (sh) 2003-02-28
EE04657B1 (et) 2006-08-15
EE200100147A (et) 2002-06-17
DK1112065T3 (da) 2004-04-05
KR100732187B1 (ko) 2007-06-27
HUP0103454A2 (hu) 2002-01-28
SK3072001A3 (en) 2002-05-09
AU5748299A (en) 2000-04-03
US6599530B2 (en) 2003-07-29
NO20011278D0 (no) 2001-03-13
EP1112065A1 (de) 2001-07-04
NO331641B1 (no) 2012-02-13
EP1112065B1 (de) 2003-12-17
CA2342634C (en) 2008-01-29
CA2342634A1 (en) 2000-03-23
AU746889B2 (en) 2002-05-02
JP4619537B2 (ja) 2011-01-26
CO5130008A1 (es) 2002-02-27
PT1112065E (pt) 2004-04-30
PE20001060A1 (es) 2000-10-20
HK1039750A1 (en) 2002-05-10
GEP20033062B (en) 2003-09-25
DE69913714D1 (de) 2004-01-29
ES2213381T3 (es) 2004-08-16
CN1151778C (zh) 2004-06-02
AR021806A1 (es) 2002-08-07
BG105436A (en) 2001-11-30
MY124394A (en) 2006-06-30
EA200100354A1 (ru) 2001-08-27
PL193454B1 (pl) 2007-02-28
HUP0103454A3 (en) 2003-11-28
HRP20010277A2 (en) 2002-06-30
NO20011278L (no) 2001-03-13

Similar Documents

Publication Publication Date Title
SK284049B6 (sk) Orálny prostriedok a spôsob jeho prípravy
AU2019272064B2 (en) High dosage strength tablets of rucaparib
JP3037757B2 (ja) パロキセチン錠およびその製法
US20030158261A1 (en) Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
US20040062800A1 (en) Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
JPH11512736A (ja) Ｎ−プロパルギル−１−アミノインダンを含有する安定な組成物
CA2483199A1 (en) High drug load tablet of imatinib
KR20090016611A (ko) 메만틴의 약학 조성물
EP1321142A1 (de) Feste orale Zubereitung mit Tegaserod
CA2471715A1 (en) A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
JPH04224514A (ja) 薬物のタブレット組成物およびその製造法
EP2293791B1 (de) Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
NZ207768A (en) Sustained release tablets comprising dipyridamole
US20030229101A1 (en) Tablets comprising ciprofloxacin hydrochloride
KR100546047B1 (ko) 디히드로피리딘계 화합물의 서방출성 제제 및 그 제조방법
CA2343949A1 (en) Benazepril hydrochloride tablet formulations
MXPA01002650A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
EP3843702A1 (de) Festdosiskombination mit schneller freisetzung von memantin und donepezil
ZA200405079B (en) A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof.
KR20010056192A (ko) 염산 서트랄린 경구투여용 조성물

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20190913